• 1106 Citations
  • 15 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where L. Nemes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Hemophilia A Medicine & Life Sciences
Factor VIII Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Hungary Medicine & Life Sciences
Safety Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Registries Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 1106 Citations
  • 15 h-Index
  • 43 Article

Cellular factor XIII, a transglutaminase in human corneal keratocytes

Orosz, Z. Z., Bárdos, H., Shemirani, A. H., Debreceni, I. B., Lassila, R., Riikonen, A. S., Kremer Hovinga, J. A., Seiler, T. G., van Dorland, H. A., Schroeder, V., Boda, Z., Nemes, L., Eppstein, B. F., Nagy, B., Facskó, A., Kappelmayer, J. & Muszbek, L., dec. 2019, In : International journal of molecular sciences. 20, 23, 5963.

Research output: Article

Open Access
Corneal Keratocytes
CD34 Antigens
Factor XIII
Transglutaminases
cornea

Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement

Tiede, A., Giangrande, P., Teitel, J., Amano, K., Benson, G., Nemes, L., Jiménez-Yuste, V., d'Oiron, R., Benchikh El Fegoun, S. & Kessler, C. M., jan. 1 2019, (Accepted/In press) In : Haemophilia.

Research output: Article

Open Access
Hemophilia A
Hemostatics
Hemorrhage
Therapeutics
Physicians

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years

Kittler, S. F. K., Miesbach, W., Bauhofer, A., Becker, T., Schüttrumpf, J., Dubovy, P., Nemes, L., Richter, H. & Königs, C., jan. 1 2019, In : Hamostaseologie. 39, 4, p. 360-367 8 p.

Research output: Article

Factor VIII
Hemophilia A
von Willebrand Factor
Safety
Therapeutics